Corvus Pharmaceuticals, Inc. CRVS

Set alert

9.83 USD +0.13 (+1.34%)

At closeNov 3, 2026, 5:00 PM EST

9.98 +0.15 +1.57%

After hours · Nov 3, 5:00 PM ET

9.73 Day range 10.06

6.39 52-week range 26.95

Held by insiders 3.51%

Held by institutions 85.73%

Float held by institutions 88.84%

Institutions 235

Top institutional holders
Holder	% held	Shares	Value	Reported
Orbimed Advisors LLC.	8.52%	7,165,006	89.85M	Jun 29, 2026
Blackrock Inc.	8.49%	7,138,811	89.52M	Jun 29, 2026
State Street Corporation	5.32%	4,474,091	56.11M	Jun 29, 2026
Price (T.Rowe) Associates Inc	4.50%	3,789,126	47.52M	Jun 29, 2026
Vanguard Capital Management LLC	3.91%	3,292,710	41.29M	Jun 29, 2026
Adams Street Partners, LLC	3.89%	3,275,616	41.08M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	3.68%	3,094,939	38.81M	Aug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.82%	2,374,106	29.77M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.06%	1,733,385	21.74M	Jul 30, 2026
Manager Directed Portfolios-Hood River Small-Cap Growth Fund	1.94%	1,632,008	20.47M	Jul 30, 2026
T. Rowe Price New Horizons Fund, Inc.	1.15%	963,958	12.09M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	1.00%	844,722	10.59M	Jun 29, 2026

CRVS insiders
Insider	Relation	Latest transaction	Date	Shares held
JONES WILLIAM BENTON	Officer	Conversion of Exercise of derivative security	Jun 3, 2025	173,130
MILLER RICHARD A	Chief Executive Officer	Purchase	May 17, 2026	0
MOORE DAVID SCOTT	Director	Purchase	Jun 10, 2026	21,700
ORBIMED ADVISORS, L.L.C.	Beneficial Owner of more than 10% of a Class of Security	Sale	Jun 26, 2025	0
THOMPSON PETER A	Director and Beneficial Owner of more than 10% of a Class of Security	Sale	Jun 26, 2025	0

Held by funds